Clinical trial
A Study of Abatacept in Japanese Patients With Active Rheumatoid Arthritis While…
NCT00345748 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00345748 |
|---|---|
| Title | A Study of Abatacept in Japanese Patients With Active Rheumatoid Arthritis While Receiving Methotrexate |
| Official title | A Phase II, Multi-center, Randomized, Double-Blind, Placebo Controlled, Dose Response Study to Evaluate the Safety and Efficacy of Two Different Doses of Abatacept (BMS-188667) Administered Intravenously to Japanese Subjects With Active Rheumatoid Arthritis While Receiving Methotrexate |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | Abatacept, Placebo |
| Enrollment | 194 |
| Start date | Jun 1, 2006 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Jun 28, 2006 |
| Last update posted | Apr 25, 2011 |
| Countries | Japan |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: